Literature DB >> 23983380

Acupuncture in treating hepatic fibrosis: a review with recommendation for future studies.

Jue Zhou1, Yi Liang, Xian-Ming Lin, Rui-Jie Ma, Jian-Qiao Fang.   

Abstract

Hepatic fibrosis, as a major medical problem, is characterized with significant morbidity and mortality. Acupuncture has potential advantages in treating hepatic fibrosis as acupuncture functions well to reduce Qi and Blood stagnation, resolve stasis and enhance body immunity, which are important factors in treating hepatic fibrosis. The aim of this review was to appraise the current limited evidence of acupuncture in treating hepatic fibrosis from both animal experiments and clinical trials by using both Chinese and western databases and to provide recommendations for future studies.

Entities:  

Keywords:  Acupuncture; hepatic fibrosis; review

Mesh:

Year:  2012        PMID: 23983380      PMCID: PMC3746655          DOI: 10.4314/ajtcam.v9i4.1

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  41 in total

Review 1.  Complementary and alternative medicine in chronic liver disease.

Authors:  L B Seeff; K L Lindsay; B R Bacon; T F Kresina; J H Hoofnagle
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

2.  Blood fluidity enhancement by electrical acupuncture stimulation is related to an adrenergic mechanism.

Authors:  Shintaro Ishikawa; Hiroki Suga; Masaya Fukushima; Atsuhiro Yoshida; Yuri Yoshida; Masataka Sunagawa; Tadashi Hisamitsu
Journal:  J Acupunct Meridian Stud       Date:  2011-12-17

3.  Investigating alternative medicine therapies in randomized controlled trials.

Authors:  A Margolin; S K Avants; H D Kleber
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

Review 4.  Mechanism of acupuncture regulating visceral sensation and mobility.

Authors:  Peijing Rong; Bing Zhu; Yuqing Li; Xinyan Gao; Hui Ben; Yanhua Li; Liang Li; Wei He; Rupeng Liu; Lingling Yu
Journal:  Front Med       Date:  2011-06-22       Impact factor: 4.592

5.  Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats.

Authors:  J P Zhang; M Zhang; J P Zhou; F T Liu; B Zhou; W F Xie; C Guo
Journal:  Acta Pharmacol Sin       Date:  2001-02       Impact factor: 6.150

6.  How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?

Authors:  G Sebastiani; A Alberti
Journal:  J Viral Hepat       Date:  2012-01       Impact factor: 3.728

Review 7.  History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells.

Authors:  A Geerts
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

8.  Induction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells.

Authors:  Ji Young Kim; Kyoung Mi Kim; Ji-Xing Nan; Yu Zhe Zhao; Pil-Hoon Park; Sang Jun Lee; Dong Hwan Sohn
Journal:  Pharmacol Toxicol       Date:  2003-04

9.  Protective effects of Danshen (Salvia miltiorrhiza) on adriamycin-induced cardiac and hepatic toxicity in rats.

Authors:  Jyh-Sheng You; Tai-Long Pan; Ying-Shiung Lee
Journal:  Phytother Res       Date:  2007-12       Impact factor: 5.878

10.  Chinese medicines as a resource for liver fibrosis treatment.

Authors:  Yibin Feng; Kwok-Fan Cheung; Ning Wang; Ping Liu; Tadashi Nagamatsu; Yao Tong
Journal:  Chin Med       Date:  2009-08-20       Impact factor: 5.455

View more
  1 in total

1.  Prolonged Survival in a Patient with Idiopathic Pulmonary Fibrosis Receiving Acupuncture and DHEA-Promoting Herbs with Conventional Management: A Case Report.

Authors:  Paul Kalnins; Mikael Brucker; Donald Spears
Journal:  Perm J       Date:  2019
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.